Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Intranasally Administered Exosomes from Umbilical Cord Stem Cells Have Preventive Neuroprotective Effects and Contribute to Functional Recovery after Perinatal Brain Injury.

Thomi G, Joerger-Messerli M, Haesler V, Muri L, Surbek D, Schoeberlein A.

Cells. 2019 Aug 8;8(8). pii: E855. doi: 10.3390/cells8080855.

2.

Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury.

Thomi G, Surbek D, Haesler V, Joerger-Messerli M, Schoeberlein A.

Stem Cell Res Ther. 2019 Mar 21;10(1):105. doi: 10.1186/s13287-019-1207-z.

3.

In vitro-microenvironment directs preconditioning of human chorion derived MSC promoting differentiation of OPC-like cells.

Periasamy R, Surbek DV, Schoeberlein A.

Tissue Cell. 2018 Jun;52:65-70. doi: 10.1016/j.tice.2018.04.002. Epub 2018 Apr 7.

PMID:
29857830
4.

Extracellular Vesicles Derived from Wharton's Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells.

Joerger-Messerli MS, Oppliger B, Spinelli M, Thomi G, di Salvo I, Schneider P, Schoeberlein A.

Cell Transplant. 2018 Jan;27(1):168-180. doi: 10.1177/0963689717738256.

5.

Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact.

Oppliger B, Joerger-Messerli MS, Simillion C, Mueller M, Surbek DV, Schoeberlein A.

Cytotherapy. 2017 Jul;19(7):829-838. doi: 10.1016/j.jcyt.2017.03.075. Epub 2017 Apr 27.

PMID:
28457739
6.

Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate.

Mueller M, Oppliger B, Joerger-Messerli M, Reinhart U, Barnea E, Paidas M, Kramer BW, Surbek DV, Schoeberlein A.

Stem Cells Dev. 2017 Feb 15;26(4):239-248. doi: 10.1089/scd.2016.0108. Epub 2016 Dec 16.

PMID:
27842457
7.

Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage.

Oppliger B, Joerger-Messerli M, Mueller M, Reinhart U, Schneider P, Surbek DV, Schoeberlein A.

Stem Cells Dev. 2016 Aug 15;25(16):1234-42. doi: 10.1089/scd.2016.0027.

PMID:
27392671
8.

Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity?

Mueller M, Wolfs TG, Schoeberlein A, Gavilanes AW, Surbek D, Kramer BW.

Mol Cell Pediatr. 2016 Dec;3(1):6. doi: 10.1186/s40348-016-0034-x. Epub 2016 Feb 11.

9.

Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.

Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek DV, Schoeberlein A.

Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:30-44. doi: 10.1016/j.bpobgyn.2015.07.006. Epub 2015 Sep 10. Review.

PMID:
26482184
10.

PreImplantation factor promotes neuroprotection by targeting microRNA let-7.

Mueller M, Zhou J, Yang L, Gao Y, Wu F, Schoeberlein A, Surbek D, Barnea ER, Paidas M, Huang Y.

Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13882-7. doi: 10.1073/pnas.1411674111. Epub 2014 Sep 9.

11.

Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells.

Joerger-Messerli M, Brühlmann E, Bessire A, Wagner A, Mueller M, Surbek DV, Schoeberlein A.

J Matern Fetal Neonatal Med. 2015 Mar;28(4):464-9. doi: 10.3109/14767058.2014.921671. Epub 2014 Jun 5.

PMID:
24803009
12.

Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential.

Messerli M, Wagner A, Sager R, Mueller M, Baumann M, Surbek DV, Schoeberlein A.

Reprod Sci. 2013 Dec;20(12):1455-64. doi: 10.1177/1933719113488443. Epub 2013 May 13.

13.

Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model.

Schoeberlein A, Mueller M, Reinhart U, Sager R, Messerli M, Surbek DV.

Am J Obstet Gynecol. 2011 Sep;205(3):277.e1-6. doi: 10.1016/j.ajog.2011.06.044. Epub 2011 Jun 17.

PMID:
22071064
14.

Generation of an osteogenic graft from human placenta and placenta-derived mesenchymal stem cells.

Mohr S, Portmann-Lanz CB, Schoeberlein A, Sager R, Surbek DV.

Reprod Sci. 2010 Nov;17(11):1006-15. doi: 10.1177/1933719110377471.

PMID:
20940246
15.

Turning placenta into brain: placental mesenchymal stem cells differentiate into neurons and oligodendrocytes.

Portmann-Lanz CB, Schoeberlein A, Portmann R, Mohr S, Rollini P, Sager R, Surbek DV.

Am J Obstet Gynecol. 2010 Mar;202(3):294.e1-294.e11. doi: 10.1016/j.ajog.2009.10.893. Epub 2010 Jan 8.

PMID:
20060088
16.

Fetal gene therapy: opportunities and risks.

Wagner AM, Schoeberlein A, Surbek D.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):813-21. doi: 10.1016/j.addr.2009.04.011. Epub 2009 May 6. Review.

PMID:
19426772
17.

Perinatal stem-cell and gene therapy for hemoglobinopathies.

Surbek D, Schoeberlein A, Wagner A.

Semin Fetal Neonatal Med. 2008 Aug;13(4):282-90. doi: 10.1016/j.siny.2008.03.002. Epub 2008 Apr 16.

PMID:
18420474
18.

Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration.

Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV.

Am J Obstet Gynecol. 2006 Mar;194(3):664-73.

PMID:
16522395
19.

Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses.

Schoeberlein A, Holzgreve W, Dudler L, Hahn S, Surbek DV.

Am J Obstet Gynecol. 2005 Apr;192(4):1044-52.

PMID:
15846178
20.

Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice.

Schoeberlein A, Schatt S, Troeger C, Surbek D, Holzgreve W, Hahn S.

Stem Cells Dev. 2004 Dec;13(6):677-84.

PMID:
15684835

Supplemental Content

Loading ...
Support Center